Targeting the sarcomere to correct muscle function
The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Abstract
Various human diseases can disrupt the balance between muscle contraction and relaxation. Sarcomeric modulators can be used to readjust this balance either indirectly by intervening in signalling pathways or directly through interaction with the muscle proteins that control contraction. Such agents represent a novel approach to treating any condition in which striated muscle function is compromised, including heart failure, cardiomyopathies, skeletal myopathies and a wide range of neuromuscular conditions. Here, we review agents that modulate the mechanical function of the sarcomere, focusing on emerging compounds that target myosin or the troponin complex.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although the Z-disk is traditionally viewed as a structural component of the sarcomere, emerging evidence indicates Z-disks are epicenters for signaling in the sarcomere with a number of different kinases and phosphatases localized to the Z-disk (6, 50).”
From Distinct hypertrophic cardiomyopathy genotypes result in convergent sarcomeric proteoform profiles revealed by top-down proteomics (2020) · cites this paper as [6]
Citations
Cites
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
THE COLORIMETRIC DETERMINATION OF PHOSPHORUS
Fiske, C. H., & Subbarow, Y. (1925) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)84756-1 · Cited by 18,997
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs104 · Cited by 6,879
The Regulation of Rabbit Skeletal Muscle Contraction
Spudich, J. A., & Watt, S. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62016-2 · Cited by 4,493
Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
Packer, M., Carver, J. R., Rodeheffer, R. J., Ivanhoe, R. J., DiBianco, R., Zeldis, S. M., Hendrix, G. H., Bommer, W. J., Elkayam, U., Kukin, M. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111213252103 · Cited by 2,225
Exercise Metabolism and the Molecular Regulation of Skeletal Muscle Adaptation
Egan, B., & Zierath, J. R. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.12.012 · Cited by 2,084
Myocardial Substrate Metabolism in the Normal and Failing Heart
Stanley, W. C., Recchia, F. A., & Lopaschuk, G. D. (2005) · Physiological Reviews · doi:10.1152/physrev.00006.2004 · Cited by 2,048
Rowland, L. P., & Shneider, N. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442207 · Cited by 1,812
HUXLEY, H., & HANSON, J. (1954) · Nature · doi:10.1038/173973a0 · Cited by 1,751
Truncations of titin causing dilated cardiomyopathy
Herman, D. S., Lam, L., Taylor, M. R. G., Wang, L., Teekakirikul, P., Christodoulou, D., Conner, L., DePalma, S. R., McDonough, B., Sparks, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110186 · Cited by 1,485
Cardiac Hypertrophy: The Good, the Bad, and the Ugly
Frey, N., & Olson, E. N. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142243 · Cited by 1,449
Geisterfer-Lowrance, A. A. T., Kass, S., Tanigawa, G., Vosberg, H.-P., McKenna, W., Seidman, C. E., & Seidman, J. G. (1990) · Cell · doi:10.1016/0092-8674(90)90274-i · Cited by 1,380
[18] Purification of muscle actin
Pardee, J. D., & Aspudich, J. (1982) · Methods in Enzymology · doi:10.1016/0076-6879(82)85020-9 · Cited by 1,186
Substructure of the myosin molecule
Weeds, A. G., & Lowey, S. (1971) · Journal of Molecular Biology · doi:10.1016/0022-2836(71)90074-x · Cited by 1,065
Mechanism of Blebbistatin Inhibition of Myosin II
Kovács, M., Tóth, J., Hetényi, C., Málnási-Csizmadia, A., & Sellers, J. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405319200 · Cited by 1,019
Mebazaa, A., Nieminen, M. S., Packer, M., Cohen-Solal, A., Kleber, F. X., Pocock, S. J., Thakkar, R., Padley, R. J., Põder, P., Kivikko, M., et al. (2007) · JAMA · doi:10.1001/jama.297.17.1883 · Cited by 994
[7] Preparation of myosin and its subfragments from rabbit skeletal muscle
Margossian, S. S., & Lowey, S. (1982) · Methods in Enzymology · doi:10.1016/0076-6879(82)85009-x · Cited by 980
Mutations in the Genes for Cardiac Troponin T and α-Tropomyosin in Hypertrophic Cardiomyopathy
Watkins, H., McKenna, W. J., Thierfelder, L., Suk, H. J., Anan, R., O'Donoghue, A., Spirito, P., Matsumori, A., Moravec, C. S., Seidman, J. G., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504203321603 · Cited by 937
Structure of the core domain of human cardiac troponin in the Ca2+-saturated form
Takeda, S., Yamashita, A., Maeda, K., & Maéda, Y. (2003) · Nature · doi:10.1038/nature01780 · Cited by 789
Substructure of the myosin molecule
Lowey, S., Slayter, H. S., Weeds, A. G., & Baker, H. (1969) · Journal of Molecular Biology · doi:10.1016/0022-2836(69)90483-5 · Cited by 771
Epidemiology and clinical course of heart failure with preserved ejection fraction
Lam, C. S. P., Donal, E., Kraigher-Krainer, E., & Vasan, R. S. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq121 · Cited by 709
Genetics of Hypertrophic Cardiomyopathy After 20 Years
Maron, B. J., Maron, M. S., & Semsarian, C. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.068 · Cited by 701
Rehospitalization for Heart Failure: Predict or Prevent?
Desai, A. S., & Stevenson, L. W. (2012) · Circulation · doi:10.1161/circulationaha.112.125435 · Cited by 613
Watkins, H., Conner, D., Thierfelder, L., Jarcho, J. A., MacRae, C., McKenna, W. J., Maron, B. J., Seidman, J. G., & Seidman, C. E. (1995) · Nature Genetics · doi:10.1038/ng1295-434 · Cited by 590
Cardiac Myosin Activation: A Potential Therapeutic Approach for Systolic Heart Failure
Malik, F. I., Hartman, J. J., Elias, K. A., Morgan, B. P., Rodriguez, H., Brejc, K., Anderson, R. L., Sueoka, S. H., Lee, K. H., Finer, J. T., et al. (2011) · Science · doi:10.1126/science.1200113 · Cited by 584
Poetter, K., Jiang, H., Hassanzadeh, S., Master, S. R., Chang, A., Dalakas, M. C., Rayment, I., Sellers, J. R., Fananapazir, L., & Epstein, N. D. (1996) · Nature Genetics · doi:10.1038/ng0596-63 · Cited by 582
Calcium Fluxes Involved in Control of Cardiac Myocyte Contraction
Bers, D. M. (2000) · Circulation Research · doi:10.1161/01.res.87.4.275 · Cited by 580
Curtis, J. P., Sokol, S. I., Wang, Y., Rathore, S. S., Ko, D. T., Jadbabaie, F., Portnay, E. L., Marshalko, S. J., Radford, M. J., & Krumholz, H. M. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00789-7 · Cited by 579
Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy
Kimura, A., Harada, H., Park, J.-E., Nishi, H., Satoh, M., Takahashi, M., Hiroi, S., Sasaoka, T., Ohbuchi, N., Nakamura, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0897-379 · Cited by 577
Titin: major myofibrillar components of striated muscle.
Wang, K., McClure, J., & Tu, A. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.8.3698 · Cited by 546
Mutations in Cypher/ZASPin patients with dilated cardiomyopathy and left ventricular non-compaction
Vatta, M., Mohapatra, B., Jimenez, S., Sanchez, X., Faulkner, G., Perles, Z., Sinagra, G., Lin, J.-H., Vu, T. M., Zhou, Q., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.021 · Cited by 524
Parry, D. A. D., & Squire, J. M. (1973) · Journal of Molecular Biology · doi:10.1016/0022-2836(73)90527-5 · Cited by 498
Genetic mutations and mechanisms in dilated cardiomyopathy
McNally, E. M., Golbus, J. R., & Puckelwartz, M. J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62862 · Cited by 478
Packer, M., Colucci, W., Fisher, L., Massie, B. M., Teerlink, J. R., Young, J., Padley, R. J., Thakkar, R., Delgado-Herrera, L., Salon, J., et al. (2013) · JACC: Heart Failure · doi:10.1016/j.jchf.2012.12.004 · Cited by 436
Structural and Functional Insights into the Myosin Motor Mechanism
Sweeney, H. L., & Houdusse, A. (2010) · Annual Review of Biophysics · doi:10.1146/annurev.biophys.050708.133751 · Cited by 422
Gautel, M., Zuffardi, O., Freiburg, A., & Labeit, S. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07187.x · Cited by 411
Mutations in the skeletal muscle α-actin gene in patients with actin myopathy and nemaline myopathy
Nowak, K. J., Wattanasirichaigoon, D., Goebel, H. H., Wilce, M., Pelin, K., Donner, K., Jacob, R. L., Hübner, C., Oexle, K., Anderson, J. R., et al. (1999) · Nature Genetics · doi:10.1038/13837 · Cited by 408
The purification of cardiac myofibrils with Triton X-100
Solaro, R. J., Pang, D. C., & Briggs, F. N. (1971) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(71)90033-8 · Cited by 407
Boswell‐Smith, V., Spina, D., & Page, C. P. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706495 · Cited by 405
Calcium cycling proteins and heart failure: mechanisms and therapeutics
Marks, A. R. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62834 · Cited by 402
Phosphorylation of troponin I and the inotropic effect of adrenaline in the perfused rabbit heart
SOLARO, R. J., MOIR, A. J. G., & PERRY, S. V. (1976) · Nature · doi:10.1038/262615a0 · Cited by 395
Specificity of blebbistatin, an inhibitor of myosin II
Limouze, J., Straight, A. F., Mitchison, T., & Sellers, J. R. (2004) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-004-6060-7 · Cited by 386
Keravis, T., & Lugnier, C. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01729.x · Cited by 385
Chou, R., Peterson, K., & Helfand, M. (2004) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2004.05.002 · Cited by 375
[22] Preparation of troponin and its subnits
Potter, J. D. (1982) · Methods in Enzymology · doi:10.1016/0076-6879(82)85024-6 · Cited by 356
A mutation in the α tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy
Laing, N. G., Wilton, S. D., Akkari, P. A., Dorosz, S., Boundy, K., Kneebone, C., Blumbergs, P., White, S., Watkins, H., Love, D. R., et al. (1995) · Nature Genetics · doi:10.1038/ng0195-75 · Cited by 356
A small-molecule inhibitor of skeletal muscle myosin II
Cheung, A., Dantzig, J. A., Hollingworth, S., Baylor, S. M., Goldman, Y. E., Mitchison, T. J., & Straight, A. F. (2002) · Nature Cell Biology · doi:10.1038/ncb734 · Cited by 342
Structure of the Rigor Actin-Tropomyosin-Myosin Complex
Behrmann, E., Müller, M., Penczek, P. A., Mannherz, H. G., Manstein, D. J., & Raunser, S. (2012) · Cell · doi:10.1016/j.cell.2012.05.037 · Cited by 341
Moreira, E. S., Wiltshire, T. J., Faulkner, G., Nilforoushan, A., Vainzof, M., Suzuki, O. T., Valle, G., Reeves, R., Zatz, M., Passos-Bueno, M. R., et al. (2000) · Nature Genetics · doi:10.1038/72822 · Cited by 337
Cleland, J. G., Teerlink, J. R., Senior, R., Nifontov, E. M., Mc Murray, J. J., Lang, C. C., Tsyrlin, V. A., Greenberg, B. H., Mayet, J., Francis, D. P., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61126-4 · Cited by 333
Spinal Muscular Atrophy: A Timely Review
Kolb, S. J. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.74 · Cited by 333
A Novel Nemaline Myopathy in the Amish Caused by a Mutation in Troponin T1
Johnston, J. J., Kelley, R. I., Crawford, T. O., Morton, D. H., Agarwala, R., Koch, T., Schäffer, A. A., Francomano, C. A., & Biesecker, L. G. (2000) · The American Journal of Human Genetics · doi:10.1086/303089 · Cited by 328
Cardiac Myosin Binding Protein C: Its Role in Physiology and Disease
Flashman, E., Redwood, C., Moolman-Smook, J., & Watkins, H. (2004) · Circulation Research · doi:10.1161/01.res.0000127175.21818.c2 · Cited by 323
Levosimendan: Molecular mechanisms and clinical implications
Papp, Z., Édes, I., Fruhwald, S., De Hert, S. G., Salmenperä, M., Leppikangas, H., Mebazaa, A., Landoni, G., Grossini, E., Caimmi, P., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.07.022 · Cited by 319
The structural basis of blebbistatin inhibition and specificity for myosin II
Allingham, J. S., Smith, R., & Rayment, I. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb908 · Cited by 312
Ca 2+ -regulated structural changes in troponin
Vinogradova, M. V., Stone, D. B., Malanina, G. G., Karatzaferi, C., Cooke, R., Mendelson, R. A., & Fletterick, R. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408882102 · Cited by 309
Vorgerd, M., van der Ven, P. F. M., Bruchertseifer, V., Löwe, T., Kley, R. A., Schröder, R., Lochmüller, H., Himmel, M., Koehler, K., Fürst, D. O., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/431959 · Cited by 309
Molecular regulation of cardiac hypertrophy
Barry, S. P., Davidson, S. M., & Townsend, P. A. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.02.020 · Cited by 306
Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan
Haikala, H. (1995) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(95)90009-8 · Cited by 304
Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy
Hayashi, T., Arimura, T., Itoh-Satoh, M., Ueda, K., Hohda, S., Inagaki, N., Takahashi, M., Hori, H., Yasunami, M., Nishi, H., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.08.058 · Cited by 302
Bang, M.-L., Mudry, R. E., McElhinny, A. S., Trombitás, K., Geach, A. J., Yamasaki, R., Sorimachi, H., Granzier, H., Gregorio, C. C., & Labeit, S. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.2.413 · Cited by 296
Mutations in myotilin cause myofibrillar myopathy
Selcen, D., & Engel, A. G. (2004) · Neurology · doi:10.1212/01.wnl.0000123576.74801.75 · Cited by 295
Myotilin is mutated in limb girdle muscular dystrophy 1A
Hauser, M. A. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.14.2141 · Cited by 291
Myofilament length dependent activation
de Tombe, P. P., Mateja, R. D., Tachampa, K., Mou, Y. A., Farman, G. P., & Irving, T. C. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.12.017 · Cited by 287
Freiburg, A., & Gautel, M. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00317.x · Cited by 278
Mutations in ZASP define a novel form of muscular dystrophy in humans
Selcen, D., & Engel, A. G. (2005) · Annals of Neurology · doi:10.1002/ana.20376 · Cited by 266
[21] Preparation and identification of α- and β-tropomyosins
Smillie, L. B. (1982) · Methods in Enzymology · doi:10.1016/0076-6879(82)85023-4 · Cited by 265
Teerlink, J. R., Clarke, C. P., Saikali, K. G., Lee, J. H., Chen, M. M., Escandon, R. D., Elliott, L., Bee, R., Habibzadeh, M. R., Goldman, J. H., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61219-1 · Cited by 262
Muscle Giants: Molecular Scaffolds in Sarcomerogenesis
Kontrogianni-Konstantopoulos, A., Ackermann, M. A., Bowman, A. L., Yap, S. V., & Bloch, R. J. (2009) · Physiological Reviews · doi:10.1152/physrev.00017.2009 · Cited by 259
Binding of Cardiac Troponin-I147-163 Induces a Structural Opening in Human Cardiac Troponin-C,
Li, M. X., Spyracopoulos, L., & Sykes, B. D. (1999) · Biochemistry · doi:10.1021/bi9901679 · Cited by 258
Self-citationFilamins in Mechanosensing and Signaling
Razinia, Z., Mäkelä, T., Ylänne, J., & Calderwood, D. A. (2012) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-050511-102252 · Cited by 252
Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice
Baudenbacher, F., Schober, T., Pinto, J. R., Sidorov, V. Y., Hilliard, F., Solaro, R. J., Potter, J. D., & Knollmann, B. C. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36642 · Cited by 248
The vertebrate muscle Z-disc: sarcomere anchor for structure and signalling
Luther, P. K. (2009) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-009-9189-6 · Cited by 247
Structure of co-crystals of tropomyosin and troponin
White, S. P., Cohen, C., & Phillips Jr, G. N. (1987) · Nature · doi:10.1038/325826a0 · Cited by 240
Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure
Teerlink, J. R., Felker, G. M., McMurray, J. J. V., Ponikowski, P., Metra, M., Filippatos, G. S., Ezekowitz, J. A., Dickstein, K., Cleland, J. G. F., Kim, J. B., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.01.031 · Cited by 235
Pollesello, P., Ovaska, M., Kaivola, J., Tilgmann, C., Lundström, K., Kalkkinen, N., Ulmanen, I., Nissinen, E., & Taskinen, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61945-9 · Cited by 232
Tragedy in a heartbeat: malfunctioning desmin causes skeletal and cardiac muscle disease
Goldfarb, L. G., & Dalakas, M. C. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38027 · Cited by 232
Structure and function of myosin filaments
Craig, R., & Woodhead, J. L. (2006) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2006.03.006 · Cited by 232
Landoni, G., Biondi-Zoccai, G., Greco, M., Greco, T., Bignami, E., Morelli, A., Guarracino, F., & Zangrillo, A. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e318232962a · Cited by 232
Mutations in the β-tropomyosin (TPM2) gene – a rare cause of nemaline myopathy
Donner, K., Ollikainen, M., Ridanpää, M., Christen, H.-J., Goebel, H. H., de Visser, M., Pelin, K., & Wallgren-Pettersson, C. (2002) · Neuromuscular Disorders · doi:10.1016/s0960-8966(01)00252-8 · Cited by 227
Wendt, I. R., & Stephenson, D. G. (1983) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/bf00657153 · Cited by 224
Mutations in Genes Encoding Fast-Twitch Contractile Proteins Cause Distal Arthrogryposis Syndromes
Sung, S. S., Brassington, A.-M. E., Grannatt, K., Rutherford, A., Whitby, F. G., Krakowiak, P. A., Jorde, L. B., Carey, J. C., & Bamshad, M. (2003) · The American Journal of Human Genetics · doi:10.1086/368294 · Cited by 209
Structure of Cardiac Muscle Troponin C Unexpectedly Reveals a Closed Regulatory Domain
Sia, S. K., Li, M. X., Spyracopoulos, L., Gagné, S. M., Liu, W., Putkey, J. A., & Sykes, B. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.29.18216 · Cited by 203
Self-citationTeekakirikul, P., Kelly, M. A., Rehm, H. L., Lakdawala, N. K., & Funke, B. H. (2013) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2012.09.002 · Cited by 196
Myosinopathies: pathology and mechanisms
Tajsharghi, H., & Oldfors, A. (2013) · Acta Neuropathologica · doi:10.1007/s00401-012-1024-2 · Cited by 196
Myozenin 2 Is a Novel Gene for Human Hypertrophic Cardiomyopathy
Osio, A., Tan, L., Chen, S. N., Lombardi, R., Nagueh, S. F., Shete, S., Roberts, R., Willerson, J. T., & Marian, A. J. (2007) · Circulation Research · doi:10.1161/01.res.0000263008.66799.aa · Cited by 192
Mutations in Alpha-Actinin-2 Cause Hypertrophic Cardiomyopathy
Chiu, C., Bagnall, R. D., Ingles, J., Yeates, L., Kennerson, M., Donald, J. A., Jormakka, M., Lind, J. M., & Semsarian, C. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.016 · Cited by 191
Recessive TTN truncating mutations define novel forms of core myopathy with heart disease
Chauveau, C., Bonnemann, C. G., Julien, C., Kho, A. L., Marks, H., Talim, B., Maury, P., Arne-Bes, M. C., Uro-Coste, E., Alexandrovich, A., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt494 · Cited by 191
Gruen, M., Prinz, H., & Gautel, M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00727-9 · Cited by 190
Calcium-Induced Structural Transition in the Regulatory Domain of Human Cardiac Troponin C,
Spyracopoulos, L., Li, M. X., Sia, S. K., Gagné, S. M., Chandra, M., Solaro, R. J., & Sykes, B. D. (1997) · Biochemistry · doi:10.1021/bi971223d · Cited by 187
Self-citationWallgren‐Pettersson, C., Sewry, C. A., Nowak, K. J., & Laing, N. G. (2011) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2011.10.004 · Cited by 184
Lovelock, J. D., Monasky, M. M., Jeong, E.-M., Lardin, H. A., Liu, H., Patel, B. G., Taglieri, D. M., Gu, L., Kumar, P., Pokhrel, N., et al. (2012) · Circulation Research · doi:10.1161/circresaha.111.258251 · Cited by 175
Mybpc3 gene therapy for neonatal cardiomyopathy enables long-term disease prevention in mice
Mearini, G., Stimpel, D., Geertz, B., Weinberger, F., Krämer, E., Schlossarek, S., Mourot-Filiatre, J., Stoehr, A., Dutsch, A., Wijnker, P. J. M., et al. (2014) · Nature Communications · doi:10.1038/ncomms6515 · Cited by 172
FATZ, a Filamin-, Actinin-, and Telethonin-binding Protein of the Z-disc of Skeletal Muscle
Faulkner, G., Pallavicini, A., Comelli, A., Salamon, M., Bortoletto, G., Ievolella, C., Trevisan, S., Kojić, S., Dalla Vecchia, F., Laveder, P., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007493200 · Cited by 172
Salmikangas, P. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg020 · Cited by 168
Stereoselective actions of thiadiazinones on canine cardiac myocytes and myofilaments.
Solaro, R. J., Gambassi, G., Warshaw, D. M., Keller, M. R., Spurgeon, H. A., Beier, N., & Lakatta, E. G. (1993) · Circulation Research · doi:10.1161/01.res.73.6.981 · Cited by 162
Protein kinase-A phosphorylates titin in human heart muscle and reduces myofibrillar passive tension
Krüger, M., & Linke, W. A. (2006) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-006-9090-5 · Cited by 162
Atomic model of the human cardiac muscle myosin filament
AL-Khayat, H. A., Kensler, R. W., Squire, J. M., Marston, S. B., & Morris, E. P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1212708110 · Cited by 161
Millevoi, S., Trombitás, K., Kolmerer, B., Sawa Kostin, D., Schaper, J., Pelin, K., Granzier, H. L. M., & Labeit, S. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1999 · Cited by 156
Levosimendan: current data, clinical use and future development.
Nieminen, M. S., Fruhwald, S. M., Heunks, L. M. A., Suominen, P. K., Gordon, A. C., Kivikko, M., & Pollesello, P. (2013) · Europe PMC (PubMed Central) · Cited by 153
Arimura, T., Hayashi, T., Terada, H., Lee, S.-Y., Zhou, Q., Takahashi, M., Ueda, K., Nouchi, T., Hohda, S., Shibutani, M., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311849200 · Cited by 151
Anabolic and catabolic pathways regulating skeletal muscle mass
McCarthy, J. J., & Esser, K. A. (2010) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32833781b5 · Cited by 148
Sung, S. S., Brassington, A.-M. E., Krakowiak, P. A., Carey, J. C., Jorde, L. B., & Bamshad, M. J. (2003) · The American Journal of Human Genetics · doi:10.1086/376418 · Cited by 148
Gailly, P. L. (2002) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/s1570-9639(02)00442-9 · Cited by 146
Binding of Levosimendan, a Calcium Sensitizer, to Cardiac Troponin C
Sorsa, T., Heikkinen, S., Abbott, M. B., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007484200 · Cited by 144
Russell, A. J., Hartman, J. J., Hinken, A. C., Muci, A. R., Kawas, R. F., Driscoll, L., Godinez, G. L., Lee, K. H., Márquez, D. X., Browne, W. F., et al. (2012) · Nature Medicine · doi:10.1038/nm.2618 · Cited by 142
Landstrom, A. P., Parvatiyar, M. S., Pinto, J. R., Marquardt, M. L., Bos, J. M., Tester, D. J., Ommen, S. R., Potter, J. D., & Ackerman, M. J. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.05.003 · Cited by 134
Myosin essential light chain in health and disease
Hernandez, O. M., Jones, M., Guzman, G., et al. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00931.2006 · Cited by 134
Signaling to Myosin Regulatory Light Chain in Sarcomeres
Kamm, K. E., & Stull, J. T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.198697 · Cited by 132
MacIntosh, B. R., Holash, R. J., & Renaud, J.-M. (2012) · Journal of Cell Science · doi:10.1242/jcs.093674 · Cited by 131
de Boer, J., Philpott, A. J., van Amsterdam, R. G. M., et al. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb14451.x · Cited by 130
Lehtokari, V., Pelin, K., Sandbacka, M., Ranta, S., Donner, K. M., Francesco Muntoni, A., Sewry, C. A., Angelini, C. I., Bushby, K. M. D., den Bergh, P. Y. K. V., et al. (2006) · Human Mutation · doi:10.1002/humu.20370 · Cited by 129
Schlossarek, S., Mearini, G., & Carrier, L. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.01.014 · Cited by 129
Szilágyi, S., Pollesello, P., Levijoki, J. M., Kaheinen, P., Haikala, H., Edes, I. F., & Papp, Z. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.12.005 · Cited by 125
Phosphodiesterase III inhibitors for heart failure
Amsallem, E., Kasparian, C., Haddour, G., Boissel, J., & Nony, P. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002230.pub2 · Cited by 124
Effects of Thin and Thick Filament Proteins on Calcium Binding and Exchange with Cardiac Troponin C
Davis, J. P., Norman, C., Kobayashi, T., et al. (2007) · Biophysical Journal · doi:10.1529/biophysj.106.095406 · Cited by 118
McKillop, D. F. A., Fortune, N. S., Ranatunga, K. W., et al. (1994) · Journal of Muscle Research and Cell Motility · doi:10.1007/bf00123483 · Cited by 117
The Nebulin family: an actin support group
Pappas, C. T., Bliss, K. T., Zieseniß, A., & Gregorio, C. C. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.09.005 · Cited by 116
How do MYBPC3 mutations cause hypertrophic cardiomyopathy?
Marston, S. B., Copeland, O., Gehmlich, K., Schlossarek, S., & Carrrier, L. (2011) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-011-9268-3 · Cited by 112
Purevjav, E., Arimura, T., Augustin, S., Huby, A.-C., Takagi, K., Nunoda, S., Kearney, D. L., Taylor, M. D., Terasaki, F., Bos, J. M., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds022 · Cited by 109
Histidine button engineered into cardiac troponin I protects the ischemic and failing heart
Day, S. M., Westfall, M. V., Fomicheva, E. V., Hoyer, K., Yasuda, S., Cross, N. C. L., D’Alecy, L. G., Ingwall, J. S., & Metzger, J. M. (2006) · Nature Medicine · doi:10.1038/nm1346 · Cited by 108
A review of the pharmacology and clinical uses of pimobendan.
Boyle, K. L., & Leech, E. (2012) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/j.1476-4431.2012.00768.x · Cited by 103
Small-Molecule Inhibitors of Myosin Proteins
Bond, L. M., Tumbarello, D. A., Kendrick‐Jones, J., & Buß, F. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.185 · Cited by 100
Crystal Structure of Scallop Myosin S1 in the Pre-Power Stroke State to 2.6 Å Resolution
Gourinath, S., Himmel, D. M., Brown, J. H., et al. (2003) · Structure · doi:10.1016/j.str.2003.10.013 · Cited by 99
von Nandelstadh, P., Ismail, M., Gardin, C., Suila, H., Zara, I., Belgrano, A., Valle, G., Carpen, O., & Faulkner, G. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01454-08 · Cited by 99
When contractile proteins go bad: the sarcomere and skeletal muscle disease
Laing, N. G., & Nowak, K. J. (2005) · BioEssays · doi:10.1002/bies.20269 · Cited by 99
Nebulette Mutations Are Associated With Dilated Cardiomyopathy and Endocardial Fibroelastosis
Purevjav, E., Varela, J., Morgado, M., Kearney, D. L., Li, H., Taylor, M. D., Arimura, T., Moncman, C. L., McKenna, W., Murphy, R. T., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.045 · Cited by 96
The significance of regulatory light chain phosphorylation in cardiac physiology
Scruggs, S. B., & Solaro, R. J. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.02.013 · Cited by 91
Genetics of Restrictive Cardiomyopathy
Sen‐Chowdhry, S., Syrris, P., & McKenna, W. J. (2010) · Heart Failure Clinics · doi:10.1016/j.hfc.2009.11.005 · Cited by 91
The cAMP binding protein Epac regulates cardiac myofilament function
Cazorla, O., Lucas, A., Poirier, F., Lacampagne, A., & Lezoualc'h, F. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812536106 · Cited by 86
Parsons, W. J., Ramkumar, V., & Stiles, G. L. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13325-7 · Cited by 83
Erdei, N., Papp, Z., Pollesello, P., et al. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706781 · Cited by 80
Compartmentation of c AMP signalling in cardiomyocytes in health and disease
Perera, R. K., & Nikolaev, V. O. (2013) · Acta Physiologica · doi:10.1111/apha.12077 · Cited by 79
Sato, S., Talukder, M., Sugawara, H., et al. (1998) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1998.0677 · Cited by 78
Ørstavik, Ø., Ata, S. H., Riise, J., Dahl, C. P., Andersen, G. Ø., Levy, F. O., Skomedal, T., Osnes, J., & Qvigstad, E. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12647 · Cited by 74
New Therapeutic Targets in Cardiology: Heart Failure and Arrhythmia: HCN Channels
Roubille, F., & Tardif, J. (2013) · Circulation · doi:10.1161/circulationaha.112.000145 · Cited by 74
Laing, N. G., Wilton, S. D., Akkari, P. A., Dorosz, S. M., Boundy, K. L., Kneebone, C. S., Blumbergs, P. C., White, S., Watkins, H. C., Love, D. R., et al. (1995) · Nature Genetics · Cited by 74
Wang, X., Li, M. X., & Sykes, B. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203896200 · Cited by 73
Self-citationRobertson, I. M., Sun, Y., Li, M. X., & Sykes, B. D. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.08.019 · Cited by 72
Self-citationBepridil opens the regulatory N-terminal lobe of cardiac troponin C
Li, Y., Love, M. L., Putkey, J. A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090098997 · Cited by 71
Cardiac myosin activation part 1: From concept to clinic
Malik, F. I., & Morgan, B. P. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.05.006 · Cited by 69
Lawlor, M. W., Ottenheijm, C. A. C., Lehtokari, V., et al. (2011) · Skeletal Muscle · doi:10.1186/2044-5040-1-23 · Cited by 68
Stimulation of cardiac myofilament force, ATPase activity and troponin C Ca++ binding by bepridil.
Solaro, R. J., Bousquet, P., & Johnson, J. D. (1986) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24853-4 · Cited by 66
MYBPC1 mutations impair skeletal muscle function in zebrafish models of arthrogryposis
Ha, K., Buchan, J. G., Alvarado, D. M., McCall, K., Vydyanath, A., Luther, P. K., Goldsmith, M. I., Dobbs, M. B., & Gurnett, C. A. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt344 · Cited by 62
Grimm, M. F., Haas, P., Willipinski-Stapelfeldt, B., Zimmermann, W., Rau, T., Pantel, K., Weyand, M., & Thomas Eschenhagen, A. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.09.019 · Cited by 61
Mika, D., Bobin, P., Pomérance, M., et al. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt193 · Cited by 61
Tropomyosins in Skeletal Muscle Diseases
Kee, A. J., & Hardeman, E. C. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-85766-4_12 · Cited by 60
Miyamoto, C. A., Fischman, D. A., & Reinach, F. C. (1999) · Journal of Muscle Research and Cell Motility · doi:10.1023/a:1005513312939 · Cited by 58
Hamdani, N., Paulus, W. J., van Heerebeek, L., Borbély, A., Boontje, N. M., Zuidwijk, M. J., Bronzwaer, J. G. F., Simonides, W. S., Niessen, H. W. M., Stienen, G. J. M., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp189 · Cited by 58
Cypher/ZASP Is a Novel A-kinase Anchoring Protein
Lin, C., Guo, X., Lange, S., Liu, J., Ouyang, K., Yin, X., Jiang, L., Cai, Y., Mu, Y., Sheikh, F., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.470708 · Cited by 55
Interaction of levosimendan with cardiac troponin C in the presence of cardiac troponin I peptides
Sorsa, T. A. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(03)00178-0 · Cited by 54
Mogensen, J., Perrot, A., Andersen, P. S., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.010447 · Cited by 54
Eichmüller, C., & Skrynnikov, N. R. (2005) · Journal of Biomolecular NMR · doi:10.1007/s10858-005-0658-y · Cited by 54
Zhang, Z., Tendulkar, A. P., Sun, K., et al. (2010) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2010.06.132 · Cited by 53
Small molecule-mediated refolding and activation of myosin motor function
Radke, M. B., Taft, M. H., Stapel, B., Hilfiker-Kleiner, D., Preller, M., & Manstein, D. J. (2014) · eLife · doi:10.7554/elife.01603 · Cited by 53
Troponin activator augments muscle force in nemaline myopathy patients with nebulin mutations
de Winter, J. M., Buck, D. E., Hidalgo, C. G., et al. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101470 · Cited by 52
Wijnker, P. J. M., Foster, D. B., Tsao, A. L., Frazier, A. H., dos Remedios, C. G., Murphy, A. M., Stienen, G. J. M., & van der Velden, J. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00498.2012 · Cited by 50
Merkulov, S. M., Chen, X., Chandler, M. P., & Stelzer, J. E. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.968941 · Cited by 47
Bhuiyan, M. S., Gulick, J. M., Osińska, H. E., et al. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.08.028 · Cited by 46
Dilated Cardiomyopathy: A Disease of the Myocardium
Sanbe, A. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b212023 · Cited by 44
Drug Binding to Cardiac Troponin C
Kleerekoper, Q., & Putkey, J. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.23932 · Cited by 43
Novel mutations in the sarcomeric protein myopalladin in patients with dilated cardiomyopathy
on behalf of the German Competence Network Heart Failure, Meyer, T., Ruppert, V., Ackermann, S., Richter, A., Perrot, A., Sperling, S., Posch, M. G., Maisch, B., & Pankuweit, S. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.173 · Cited by 43
Li, M. M. Q., Saude, E. J., Wang, X., Pearlstone, J. R., Smillie, L. B., & Sykes, B. D. (2002) · European Biophysics Journal · doi:10.1007/s00249-002-0227-1 · Cited by 42
Self-citationShefner, J. M., Watson, M. L., Meng, L., Wolff, A. A., & The Neals/Cytokinetics STUDY Team (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.822517 · Cited by 41
Silver, P. J., Pinto, P. B., & Dachiw, J. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90052-3 · Cited by 41
Ferroni, C. (1991) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(91)90068-w · Cited by 41
Kitada, Y., Kobayashi, M., Narimatsu, A., et al. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21353-2 · Cited by 40
Wolska, B. M., Kitada, Y., Palmiter, K. A., et al. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.270.1.h24 · Cited by 39
Claeys, K. G., & Fardeau, M. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59565-2.00005-8 · Cited by 38
Robertson, I. M., Baryshnikova, O. K., Li, M. X., et al. (2008) · Biochemistry · doi:10.1021/bi800438k · Cited by 38
Adhikari, B. B., & Wang, K. (2004) · Biophysical Journal · doi:10.1016/s0006-3495(04)74112-0 · Cited by 37
Alterations of cAMP-dependent signaling in dystrophic skeletal muscle
Rudolf, R., Khan, M. M., Lustrino, D., Labeit, S., Kettelhut, Í. D. C., & Navegantes, L. C. C. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00290 · Cited by 37
Oleszczuk, M., Robertson, I. M., Li, M. X., et al. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.01.016 · Cited by 37
Herron, T. J., Devaney, E. J., Mundada, L. V., Arden, E., Day, S. M., Guerrero‐Serna, G., Turner, I. I., Westfall, M. V., & Metzger, J. M. (2009) · The FASEB Journal · doi:10.1096/fj.09-140566 · Cited by 33
Boontje, N. M., Merkus, D., Zaremba, R., Versteilen, A. M. G., de Waard, M. C., Mearini, G., de Beer, V. J., Carrier, L., Walker, L. A., Niessen, H. W. M., et al. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.12.002 · Cited by 33
Analytical Comparison of Natural and Pharmaceutical Ventricular Myosin Activators
Wang, Y., Ajtai, K., & Burghardt, T. P. (2014) · Biochemistry · doi:10.1021/bi500730t · Cited by 32
Kawabata, Y., & Endoh, M. (1993) · Circulation Research · doi:10.1161/01.res.72.3.597 · Cited by 31
Phosphodiesterase inhibition by enoximone in preparations from nonfailing and failing human hearts.
Bethke, T. D., Eschenhagen, T., Klimkiewicz, A., et al. (1992) · PubMed · Cited by 30
Sousa, D. R., Stagg, S. M., & Stroupe, M. E. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.08.020 · Cited by 30
Brixius, K., Mehlhorn, U., Bloch, W., & Schwinger, R. H. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39031-7 · Cited by 30
The binding of the calcium channel blocker, bepridil, to calmodulin
Itoh, H., Tanaka, T., Yoshihide, M., et al. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90516-2 · Cited by 27
Myofilament Length-Dependent Activation Develops within 5 ms in Guinea-Pig Myocardium
Mateja, R. D., & de Tombe, P. P. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2012.05.034 · Cited by 26
Bethke, T. D., Meyer, W., Schmitz, W. L., et al. (1993) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199306000-00001 · Cited by 24
Rieck, D. C., Li, K., Ouyang, Y., et al. (2013) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2013.07.013 · Cited by 24
Meel, J. C. A. V., Zimmermann, R., Diederen, W., et al. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90720-4 · Cited by 24
ZASPopathy with childhood-onset distal myopathy
Strach, K. A., Reimann, J., Thomas, D., et al. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6543-1 · Cited by 22
The ‘calcium sensitising’ effects of ORG30029 in saponin‐ or Triton‐skinned rat cardiac muscle
Miller, D. J., & Steele, D. S. (1990) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1990.tb14102.x · Cited by 21
Compartmentalized cAMP signalling is important in the regulation of Ca2+ cycling in the heart
Lygren, B., & Taskén, K. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340489 · Cited by 20
Versatile Cardiac Troponin Chimera for Muscle Protein Structural Biology and Drug Discovery
Pineda-Sanabria, S. E., Julien, O., & Sykes, B. D. (2014) · ACS Chemical Biology · doi:10.1021/cb500249j · Cited by 18
Self-citationCardiac myosin binding protein-C: a novel sarcomeric target for gene therapy
Mamidi, R., Li, J., Gresham, K. S., & Stelzer, J. E. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1412-z · Cited by 18
Palmer, S. (1996) · Cardiovascular Research · doi:10.1016/0008-6363(96)00098-3 · Cited by 17
van Dijk, S. J., Holewijn, R. A., Tebeest, A., dos Remedios, C. G., Stienen, G. J. M., & van der Velden, J. (2009) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-010-9205-x · Cited by 16
The relationship between tirasemtiv serum concentration and functional outcomes in patients with ALS
Shefner, J. M., Wolff, A. A., & Meng, L. (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.817587 · Cited by 14
Kischel, P., Stevens, L., & Mounier, Y. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702820 · Cited by 14
The Myosin Duty Ratio Tunes the Calcium Sensitivity and Cooperative Activation of the Thin Filament
Webb, M., Jackson, D. R., Stewart, T. J., et al. (2013) · Biochemistry · doi:10.1021/bi400262h · Cited by 13
Yoshida, H., Itoh, S., Hara, T., Sasaki, Y., Kondō, S., Nakagawa, T., ASANUMA, A., & Tanabe, S. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.12.044 · Cited by 12
Li, M. X., Hoffman, R. M. B., & Sykes, B. D. (2006) · Biochemistry · doi:10.1021/bi060779a · Cited by 12
Self-citation
Cited by
Tucholski, T., Cai, W., Gregorich, Z. R., Bayne, E. F., Mitchell, S. D., McIlwain, S. J., de Lange, W. J., Wrobbel, M., Karp, H., Hite, Z., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2006764117 · Cited by 107
Deletion of Enigma Homologue from the Z-disc slows tension development kinetics in mouse myocardium
Gregorich, Z. R., Patel, J. R., Cai, W., Lin, Z., Heurer, R., Fitzsimons, D. P., Moss, R. L., & Ge, Y. (2019) · Journal of General Physiology · doi:10.1085/jgp.201812214 · Cited by 6
“In recent years, the importance of Z-discs, the protein-dense structures that anchor the antiparallel actin filaments from adjoining sarcomeres, in muscle has been underscored by the identification of a growing list of mutations in Z-disc proteins in patients with cardiac and skeletal muscle myopathies (Knöll et al.,…”
Background
Metadata
- Authors
- Hwang, P. M., & Sykes, B. D.
- Affiliations
- University of Alberta (CA)
- Corresponding author
- Sykes, Brian D.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2015-04-17
- Volume
- 14
- Issue
- 5
- Pages
- 313-328
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2040264002
- Cited by
- 114
- References
- 207
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 8 · 2023: 9 · 2022: 10 · 2021: 8 · 2020: 13 · 2019: 9 · 2018: 21 · 2017: 11 · 2016: 18 · 2015: 3
- FWCI
- 3.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Heart and Stroke Foundation of Canada
- Canadian Institutes of Health Research (37769)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- sarcomere, myosin, troponin complex, muscle contraction and relaxation, heart failure, cardiomyopathy, skeletal myopathy, neuromuscular disorders
- MeSH terms
- Animals, Heart Failure, Humans, Muscle Contraction, Muscle Proteins, Muscular Diseases, Cardiomyopathies, Neuromuscular Diseases, Sarcomeres, Signal Transduction, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.